Morepen Laboratories Q3 Results
- BSE: 500288
- NSE: MOREPENLAB
- ISIN: INE083A01026
- Sector: Biotechnology & Drugs
BSE
52.10
-0.17 (-0.33%)
-0.17 (-0.33%)Volume2.94 L
Updated: Wed 17 Jun, 2026 | 13:06:10
NSE
52.24-0.04 (-0.08%)
-0.04 (-0.08%)Volume4.04 M
Updated: Wed 17 Jun, 2026 | 12:53:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Morepen Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 448.23 | 395.51 | 22.35% | 402.43 | 6.32% |
| Depreciation/ Amortization | 10.38 | 1.86 | -7.97% | 8.45 | 110.59% |
| Operating Income | 35.93 | 42.21 | -20.57% | 42.12 | 15.14% |
| Net Income | 27.51 | 34.85 | -32.70% | 31.99 | 3.08% |
| Other Operating Expenses Total | 42.32 | 31.50 | 43.89% | 29.24 | 14.13% |
| Net Income Before Taxes | 35.42 | 46.02 | -22.48% | 44.02 | 0.61% |
| Total Revenue | 484.16 | 437.73 | 17.64% | 444.55 | 6.93% |
| Selling/ General/ Admin Expenses Total | 87.21 | 81.76 | 14.59% | 92.71 | 9.11% |
| Diluted Normalized EPS | 0.50 | 0.65 | 54.14% | 0.63 | 2.04% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.